Concepedia
Statistics
Publications
9
Citations
434
H-Index
Active since
1988
Affiliations
University of Southern California(Current)
Cancer Center of Kansas
University of California, Los Angeles
Massachusetts General Hospital
University of Pittsburgh
Thomas J. Lomis is an author at University of Southern California specializing in pharmacology, medicine, and chemistry.
Publications per year
1988–2023
Predicting Axillary Nodal Positivity in 2282 Patients with Breast Carcinoma
Melvin J. Silverstein, Kristin A. Skinner, Thomas J. Lomis · World Journal of Surgery · 2001 · 240 citations
Medicine, Oncology, Pathology +12
Preoperative Paclitaxel and Radiotherapy for Locally Advanced Breast Cancer: Surgical Aspects
Kristin A. Skinner, Howard Silberman, Barbara D. Florentine et al. · Annals of Surgical Oncology · 2000 · 40 citations
Medicine, Oncology, Surgery +14
TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early-stage breast cancer.
Sara A. Hurvitz, Lisa S. Wang, David W. Chan et al. · Journal of Clinical Oncology · 2022 · 39 citations
Medicine, Pharmacology, Chemotherapy +16
First place winner of the Conrad Jobst Award in the gold medal paper competition. Nitric oxide synthase inhibitors N-monomethylarginine and aminoguanidine prevent the progressive and severe hypotension associated with a rat model of pancreatitis.
Thomas J. Lomis, C. Siffring, Sridhar Chalasani et al. · PubMed · 1995 · 32 citations
Medicine, Pharmacology, Pharmacotherapy +14
Abstract GS2-03: GS2-03 TRIO-US B-12 TALENT: Neoadjuvant trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer
Aditya Bardia, Sara A. Hurvitz, Michael F. Press et al. · Cancer Research · 2023 · 31 citations
Medicine, Oncology, Pharmacology +17
1–5 of 9